Generic KRAS G12C Inhibitor Tablets

So, Adagrasib is this newfangled KRAS G12C inhibitor. It’s for treating NSCLC, especially in folks who have those G12C mutations. It zeroes in on that mutated KRAS protein, which is sort of the main troublemaker in NSCLC.

The drug comes in tablet form, and each one has 200 mg of the good stuff. Doctors usually suggest taking 600 mg twice a day. You can take the dose with or without food, whichever works for you.

Each bottle comes with 180 tablets.